Treatment adequacy for anxiety and depressive disorders in six European countries.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 17267936.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The aims of this study are to describe the adequacy of treatment for anxiety and depressive disorders in Europe and how itdiffers between providers, using data from the ESEMeD study. The overall proportion of adequate treatment was 45.8% (57.4% in the specialised sector and 23.3% in the general medical care sector). Between-country differences were found in treatment adequacy in the specialised setting. Organisational and political aspects may explain these findings.
Medical subject headings
- Anxiety Disorders
- Depressive Disorder
- Mental Health Services
- Quality of Health Care